Interferon Signature in the Blood in Inflammatory Common Variable Immune Deficiency

PLoS ONE

Volumn 8, Issue 9, 2013, Pages

  Park, Joon ^a   Munagala, Indira ^b   Xu, Hui ^d   Blankenship, Derek ^d   Maffucci, Patrick ^a   Chaussabel, Damien ^c   Banchereau, Jacques ^b   Pascual, Virginia ^b   Cunningham Rundles, Charlotte ^a  

^a MOUNT SINAI SCHOOL OF MEDICINE   (United States)

^b BAYLOR INSTITUTE FOR IMMUNOLOGY RESEARCH   (United States)

^c BENAROYA RESEARCH INSTITUTE   (United States)

^d BAYLOR HEALTH CARE SYSTEM   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

INTERFERON; TOLL LIKE RECEPTOR;

ADOLESCENT; ADULT; AGED; ARTICLE; AUTOIMMUNITY; B LYMPHOCYTE; BLOOD ANALYSIS; CHILD; COMMON VARIABLE IMMUNODEFICIENCY; CONTROLLED STUDY; DIGESTIVE SYSTEM INFLAMMATION; FEMALE; GENETIC TRANSCRIPTION; GRANULOMATOSIS; HUMAN; INFLAMMATORY DISEASE; INTERSTITIAL LUNG DISEASE; LYMPHADENOPATHY; LYMPHOCYTOPENIA; MAJOR CLINICAL STUDY; MALE; PLASMA CELL; SCHOOL CHILD; SPLENOMEGALY; T LYMPHOCYTE; UPREGULATION; X LINKED AGAMMAGLOBULINEMIA;

ADOLESCENT; ADULT; AGED; AGED, 80 AND OVER; CASE-CONTROL STUDIES; CHILD; CLUSTER ANALYSIS; COMMON VARIABLE IMMUNODEFICIENCY; FEMALE; GENE EXPRESSION PROFILING; GENE EXPRESSION REGULATION; HUMANS; INFLAMMATION; INTERFERON-ALPHA; INTERFERON-GAMMA; INTERFERONS; MALE; MIDDLE AGED; MOLECULAR SEQUENCE ANNOTATION; TRANSCRIPTOME; YOUNG ADULT;

EID: 84884274433     PISSN: None     EISSN: 19326203     Source Type: Journal    
DOI: 10.1371/journal.pone.0074893     Document Type: Article

References (64)

1. Al-Herz W, Bousfiha A, Casanova JL, Chapel H, Conley ME, et al. (2011) Primary immunodeficiency diseases: an update on the classification from the international union of immunological societies expert committee for primary immunodeficiency. Front Immunol 2: 54. PubMed: 22566844.
2. Cunningham-Rundles C, (2001) Common variable immunodeficiency. Curr Allergy Asthma Rep 1: 421-429. doi:10.1007/s11882-001-0027-1. PubMed: 11892068.
3. Park JH, Resnick ES, Cunningham-Rundles C, (2011) Perspectives on common variable immune deficiency. Ann N Y Acad Sci 1246: 41-49. doi:10.1111/j.1749-6632.2011.06338.x. PubMed: 22236429.
4. Grimbacher B, Hutloff A, Schlesier M, Glocker E, Warnatz K, et al. (2003) Homozygous loss of ICOS is associated with adult-onset common variable immunodeficiency. Nat Immunol 4: 261-268. doi:10.1038/ni902. PubMed: 12577056.
5. van Zelm MC, Reisli I, van der Burg M, Castaño D, van Noesel CJ, et al. (2006) An antibody-deficiency syndrome due to mutations in the CD19 gene. N Engl J Med 354: 1901-1912. doi:10.1056/NEJMoa051568. PubMed: 16672701.
6. Kanegane H, Agematsu K, Futatani T, Sira MM, Suga K, et al. (2007) Novel mutations in a Japanese patient with CD19 deficiency. Genes Immun 8: 663-670. doi:10.1038/sj.gene.6364431. PubMed: 17882224.
7. Warnatz K, Salzer U, Rizzi M, Fischer B, Gutenberger S, et al. (2009) B-cell activating factor receptor deficiency is associated with an adult-onset antibody deficiency syndrome in humans. Proc Natl Acad Sci U S A 106: 13945-13950. doi:10.1073/pnas.0903543106. PubMed: 19666484.
8. Kuijpers TW, Bende RJ, Baars PA, Grummels A, Derks IA, et al. (2010) CD20 deficiency in humans results in impaired T cell-independent antibody responses. J Clin Invest 120: 214-222. doi:10.1172/JCI40231. PubMed: 20038800.
9. van Zelm MC, Smet J, Adams B, Mascart F, Schandené L, et al. (2010) CD81 gene defect in humans disrupts CD19 complex formation and leads to antibody deficiency. J Clin Invest 120: 1265-1274. doi:10.1172/JCI39748. PubMed: 20237408.
10. Resnick ES, Moshier EL, Godbold JH, Cunningham-Rundles C, (2011) Morbidity and mortality in common variable immune deficiency over 4 decades. Blood 119: 1650-1657. PubMed: 22180439.
11. Baldovino S, Montin D, Martino S, Sciascia S, Menegatti E, et al. (2012) Common variable immunodeficiency: Crossroads between infections, inflammation and autoimmunity. Autoimmun Rev 12: 796-801. PubMed: 23219764.
12. Cunningham-Rundles C, (2002) Hematologic complications of primary immune deficiencies. Blood Rev 16: 61-64. doi:10.1054/blre.2001.0185. PubMed: 11913998.
13. Morimoto Y, Routes JM, (2005) Granulomatous disease in common variable immunodeficiency. Curr Allergy Asthma Rep 5: 370-375. doi:10.1007/s11882-005-0008-x. PubMed: 16091208.
14. Agarwal S, Mayer L, (2009) Pathogenesis and treatment of gastrointestinal disease in antibody deficiency syndromes. J Allergy Clin Immunol 124: 658-664. doi:10.1016/j.jaci.2009.06.018. PubMed: 19665769.
15. Chapel H, Lucas M, Lee M, Bjorkander J, Webster D, et al. (2008) Common variable immunodeficiency disorders: division into distinct clinical phenotypes. Blood 112: 277-286. doi:10.1182/blood-2007-11-124545. PubMed: 18319398.
16. Ardeniz O, Cunningham-Rundles C, (2009) Granulomatous disease in common variable immunodeficiency. Clin Immunol 133: 198-207. doi:10.1016/j.clim.2009.05.001. PubMed: 19716342.
17. Shi M, Beauchamp RD, Zhang B, (2012) A network-based gene expression signature informs prognosis and treatment for colorectal cancer patients. PLOS ONE 7: e41292. doi:10.1371/journal.pone.0041292. PubMed: 22844451.
18. Pascual V, Chaussabel D, Banchereau J, (2010) A genomic approach to human autoimmune diseases. Annu Rev Immunol 28: 535-571. doi:10.1146/annurev-immunol-030409-101221. PubMed: 20192809.
19. Berry MP, Graham CM, McNab FW, Xu Z, Bloch SA, et al. (2010) An interferon-inducible neutrophil-driven blood transcriptional signature in human tuberculosis. Nature 466: 973-977. doi:10.1038/nature09247. PubMed: 20725040.
20. Tattermusch S, Skinner JA, Chaussabel D, Banchereau J, Berry MP, et al. (2012) Systems biology approaches reveal a specific interferon-inducible signature in HTLV-1 associated myelopathy. PLOS Pathog 8: e1002480. PubMed: 22291590.
21. Ramilo O, Allman W, Chung W, Mejias A, Ardura M, et al. (2007) Gene expression patterns in blood leukocytes discriminate patients with acute infections. Blood 109: 2066-2077. doi:10.1182/blood-2006-02-002477. PubMed: 17105821.
22. Pascual V, Allantaz F, Patel P, Palucka AK, Chaussabel D, et al. (2008) How the study of children with rheumatic diseases identified interferon-alpha and interleukin-1 αs novel therapeutic targets. Immunol Rev 223: 39-59. doi:10.1111/j.1600-065X.2008.00643.x. PubMed: 18613829.
23. Chaussabel D, Allman W, Mejias A, Chung W, Bennett L, et al. (2005) Analysis of significance patterns identifies ubiquitous and disease-specific gene-expression signatures in patient peripheral blood leukocytes. Ann N Y Acad Sci 1062: 146-154. doi:10.1196/annals.1358.017. PubMed: 16461797.
24. Chapel H, Cunningham-Rundles C, (2009) Update in understanding common variable immunodeficiency disorders (CVIDs) and the management of patients with these conditions. Br J Haematol 145: 709-727. doi:10.1111/j.1365-2141.2009.07669.x. PubMed: 19344423.
25. Chaussabel D, Pascual V, Banchereau J, (2010) Assessing the human immune system through blood transcriptomics. BMC Biol 8: 84. doi:10.1186/1741-7007-8-84. PubMed: 20619006.
26. Chaussabel D, Quinn C, Shen J, Patel P, Glaser C, et al. (2008) A modular analysis framework for blood genomics studies: application to systemic lupus erythematosus. Immunity 29: 150-164. doi:10.1016/j.immuni.2008.05.012. PubMed: 18631455.
27. Benjamini Y, Hochberg Y, (1995) Controlling the False Discovery Rate: A Practical and Powerful Approach to Multiple Testing. J R Stat Soc 57: 289-300.
28. Yu JE, Knight AK, Radigan L, Marron TU, Zhang L, et al. (2009) Toll-like receptor 7 and 9 defects in common variable immunodeficiency. J Allergy Clin Immunol 124: 349-356, 356.e341-343 doi:10.1016/j.jaci.2009.05.019. PubMed: 19592080.
29. Wehr C, Kivioja T, Schmitt C, Ferry B, Witte T, et al. (2008) The EUROclass trial: defining subgroups in common variable immunodeficiency. Blood 111: 77-85. doi:10.1182/blood-2007-06-091744. PubMed: 17898316.
30. Sánchez-Ramón S, Radigan L, Yu JE, Bard S, Cunningham-Rundles C, (2008) Memory B cells in common variable immunodeficiency: Clinical associations and sex differences. Clin Immunol 128: 314-321. doi:10.1016/j.clim.2008.02.013. PubMed: 18620909.
31. Banchereau R, Jordan-Villegas A, Ardura M, Mejias A, Baldwin N, et al. (2012) Host immune transcriptional profiles reflect the variability in clinical disease manifestations in patients with Staphylococcus aureus infections. PLOS ONE 7: e34390. doi:10.1371/journal.pone.0034390. PubMed: 22496797.
32. Allantaz F, Cheng DT, Bergauer T, Ravindran P, Rossier MF, et al. (2012) Expression profiling of human immune cell subsets identifies miRNA-mRNA regulatory relationships correlated with cell type specific expression. PLOS ONE 7: e29979. doi:10.1371/journal.pone.0029979. PubMed: 22276136.
33. Ballow M, (2011) The IgG molecule as a biological immune response modifier: mechanisms of action of intravenous immune serum globulin in autoimmune and inflammatory disorders. J Allergy Clin Immunol 127: 315-323; quiz 324-315 doi:10.1016/j.jaci.2010.10.030. PubMed: 21185071.
34. Yu JE, Zhang L, Radigan L, Sanchez-Ramon S, Cunningham-Rundles C, (2012) TLR-mediated B cell defects and IFN-alpha in common variable immunodeficiency. J Clin Immunol 32: 50-60. doi:10.1007/s10875-011-9602-y. PubMed: 22048980.
35. Warnatz K, Denz A, Dräger R, Braun M, Groth C, et al. (2002) Severe deficiency of switched memory B cells (CD27(+)IgM(-)IgD(-)) in subgroups of patients with common variable immunodeficiency: a new approach to classify a heterogeneous disease. Blood 99: 1544-1551. doi:10.1182/blood.V99.5.1544. PubMed: 11861266.
36. Wehr C, Eibel H, Masilamani M, Illges H, Schlesier M, et al. (2004) A new CD21low B cell population in the peripheral blood of patients with SLE. Clin Immunol 113: 161-171. doi:10.1016/j.clim.2004.05.010. PubMed: 15451473.
37. Piqueras B, Lavenu-Bombled C, Galicier L, Bergeron-van der Cruyssen F, Mouthon L, et al. (2003) Common variable immunodeficiency patient classification based on impaired B cell memory differentiation correlates with clinical aspects. J Clin Immunol 23: 385-400. doi:10.1023/A:1025373601374. PubMed: 14601647.
38. Alachkar H, Taubenheim N, Haeney MR, Durandy A, Arkwright PD, (2006) Memory switched B cell percentage and not serum immunoglobulin concentration is associated with clinical complications in children and adults with specific antibody deficiency and common variable immunodeficiency. Clin Immunol 120: 310-318. doi:10.1016/j.clim.2006.05.003. PubMed: 16782407.
39. Isnardi I, Ng YS, Menard L, Meyers G, Saadoun D, et al. (2010) Complement receptor 2/CD21-negative human naive B cells mostly contain autoreactive unresponsive clones. Blood 115: 5026-5036. doi:10.1182/blood-2009-09-243071. PubMed: 20231422.
40. Isnardi I, Ng YS, Menard L, Meyers G, Saadoun D, et al. (2010) Complement receptor 2/CD21- human naive B cells contain mostly autoreactive unresponsive clones. Blood 115: 5026-5036. doi:10.1182/blood-2009-09-243071. PubMed: 20231422.
41. Winkelstein JA, Marino MC, Lederman HM, Jones SM, Sullivan K, et al. (2006) X-linked agammaglobulinemia: report on a United States registry of 201 patients. Medicine (Baltimore) 85: 193-202. doi:10.1097/01.md.0000229482.27398.ad. PubMed: 16862044.
42. Bucasas KL, Franco LM, Shaw CA, Bray MS, Wells JM, et al. (2011) Early patterns of gene expression correlate with the humoral immune response to influenza vaccination in humans. J Infect Dis 203: 921-929. doi:10.1093/infdis/jiq156. PubMed: 21357945.
43. Bolen CR, Robek MD, Brodsky L, Schulz V, Lim JK, et al. (2013) The blood transcriptional signature of chronic hepatitis C virus is consistent with an ongoing interferon-mediated antiviral response. J Interferon Cytokine Res 33: 15-23. doi:10.1089/jir.2012.0037. PubMed: 23067362.
44. Hardy GA, Sieg S, Rodriguez B, Anthony D, Asaad R, et al. (2013) Interferon-alpha Is the Primary Plasma Type-I IFN in HIV-1 Infection and Correlates with Immune Activation and Disease Markers. PLOS ONE 8: e56527. doi:10.1371/journal.pone.0056527. PubMed: 23437155.
45. Wheat WH, Cool CD, Morimoto Y, Rai PR, Kirkpatrick CH, et al. (2005) Possible role of human herpesvirus 8 in the lymphoproliferative disorders in common variable immunodeficiency. J Exp Med 202: 479-484. doi:10.1084/jem.20050381. PubMed: 16103407.
46. Marashi SM, Raeiszadeh M, Enright V, Tahami F, Workman S, et al. (2012) Influence of cytomegalovirus infection on immune cell phenotypes in patients with common variable immunodeficiency. J Allergy Clin Immunol 129: 1349-1356 e1343 doi:10.1016/j.jaci.2012.02.011. PubMed: 22444511.
47. Rönnblom L, Eloranta ML, (2013) The interferon signature in autoimmune diseases. Curr Opin Rheumatol 25: 248-253. doi:10.1097/BOR.0b013e32835c7e32. PubMed: 23249830.
48. Lübbers J, Brink M, van de Stadt LA, Vosslamber S, Wesseling JG, et al. (2013) The type I IFN signature as a biomarker of preclinical rheumatoid arthritis. Ann Rheum Dis 72: 776-780. doi:10.1136/annrheumdis-2012-202753. PubMed: 23434571.
49. Crow YJ, (2011) Type I interferonopathies: a novel set of inborn errors of immunity. Ann N Y Acad Sci 1238: 91-98. doi:10.1111/j.1749-6632.2011.06220.x. PubMed: 22129056.
50. Deane JA, Pisitkun P, Barrett RS, Feigenbaum L, Town T, et al. (2007) Control of toll-like receptor 7 expression is essential to restrict autoimmunity and dendritic cell proliferation. Immunity 27: 801-810. doi:10.1016/j.immuni.2007.09.009. PubMed: 17997333.
51. Rice GI, Kasher PR, Forte GM, Mannion NM, Greenwood SM, et al. (2012) Mutations in ADAR1 cause Aicardi-Goutieres syndrome associated with a type I interferon signature. Nat Genet 44: 1243-1248. doi:10.1038/ng.2414. PubMed: 23001123.
52. Crampton SP, Deane JA, Feigenbaum L, Bolland S, (2012) Ifih1 gene dose effect reveals MDA5-mediated chronic type I IFN gene signature, viral resistance, and accelerated autoimmunity. J Immunol 188: 1451-1459. doi:10.4049/jimmunol.1102705. PubMed: 22205024.
53. Garcia-Romo GS, Caielli S, Vega B, Connolly J, Allantaz F, et al. (2011) Netting neutrophils are major inducers of type I IFN production in pediatric systemic lupus erythematosus. Sci Transl Med 3: 73ra20. PubMed: 21389264.
54. Bloom CI, Graham CM, Berry MP, Wilkinson KA, Oni T, et al. (2012) Detectable changes in the blood transcriptome are present after two weeks of antituberculosis therapy. PLOS ONE 7: e46191. doi:10.1371/journal.pone.0046191. PubMed: 23056259.
55. Bernink J, Mjösberg J, Spits H, (2013) Th1- and Th2-like subsets of innate lymphoid cells. Immunol Rev 252: 133-138. doi:10.1111/imr.12034. PubMed: 23405900.
56. Kwok SK, Lee JY, Park SH, Cho ML, Min SY, et al. (2008) Dysfunctional interferon-alpha production by peripheral plasmacytoid dendritic cells upon Toll-like receptor-9 stimulation in patients with systemic lupus erythematosus. Arthritis Res Ther 10: R29. doi:10.1186/ar2382. PubMed: 18321389.
57. Hinze CH, Fall N, Thornton S, Mo JQ, Aronow BJ, et al. (2010) Immature cell populations and an erythropoiesis gene-expression signature in systemic juvenile idiopathic arthritis: implications for pathogenesis. Arthritis Res Ther 12: R123. doi:10.1186/ar3024. PubMed: 20576155.
58. Allantaz F, Chaussabel D, Banchereau J, Pascual V, (2007) Microarray-based identification of novel biomarkers in IL-1-mediated diseases. Curr Opin Immunol 19: 623-632. doi:10.1016/j.coi.2007.10.003. PubMed: 18036805.
59. Greenfest-Allen E, Malik J, Palis J, Stoeckert CJ Jr., (2013) Stat and interferon genes identified by network analysis differentially regulate primitive and definitive erythropoiesis. BMC. Syst Biol 7: 38.
60. Genre J, Errante PR, Kokron CM, Toledo-Barros M, Câmara NO, et al. (2009) Reduced frequency of CD4(+)CD25(HIGH)FOXP3(+) cells and diminished FOXP3 expression in patients with Common Variable Immunodeficiency: a link to autoimmunity? Clin Immunol 132: 215-221. doi:10.1016/j.clim.2009.03.519. PubMed: 19394278.
61. Serana F, Airò P, Chiarini M, Zanotti C, Scarsi M, et al. (2011) Thymic and bone marrow output in patients with common variable immunodeficiency. J Clin Immunol 31: 540-549. doi:10.1007/s10875-011-9526-6. PubMed: 21491094.
62. Fevang B, Yndestad A, Sandberg WJ, Holm AM, Müller F, et al. (2007) Low numbers of regulatory T cells in common variable immunodeficiency: association with chronic inflammation in vivo. Clin Exp Immunol 147: 521-525. doi:10.1111/j.1365-2249.2006.03314.x. PubMed: 17302902.
63. Sander LE, Davis MJ, Boekschoten MV, Amsen D, Dascher CC, et al. (2011) Detection of prokaryotic mRNA signifies microbial viability and promotes immunity. Nature 474: 385-389. doi:10.1038/nature10072. PubMed: 21602824.
64. Bernink J, Mjösberg J, Spits H, (2013) Th1- and Th2-like subsets of innate lymphoid cells. Immunol Rev 252: 133-138. doi:10.1111/imr.12034. PubMed: 23405900.